X4 Pharmaceuticals (XFOR) Tax Rate (2020 - 2026)
X4 Pharmaceuticals' (XFOR) quarterly Tax Rate came in at 0.01% in Q2 2026, up 13.0% on a YoY basis from 0.01% in Q2 2025, and down 112.32% quarter-over-quarter from 0.1% in Q3 2025.
Powered by 
Analysis
X4 Pharmaceuticals (XFOR) Tax Rate (2020 - 2026) Analysis & Trends
X4 Pharmaceuticals (XFOR) has reported Tax Rate for 7 consecutive years, with 0.01% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Tax Rate rose 13.0% year-over-year to 0.01%; the trailing twelve-month figure through Jun 2026 stood at 0.03% (up 37.0% YoY), and the FY2025 full-year result was 0.05%, up 78.0% from the prior year.
- Tax Rate declined to 0.01% in Q2 2026 per XFOR's latest filing, from 0.1% in the prior quarter.
- Across five years, Tax Rate topped out at 10.76% in Q1 2025 and bottomed at 1.14% in Q3 2023.
- Historically, Tax Rate has averaged 0.53% across 5 years, with a median of 0.03% in 2023.
- The sharpest annual moves came in 2023 and 2025: Tax Rate slumped 120 bps in 2023, then soared 1080 bps in 2025.
- Over 5 years, Tax Rate stood at 0.05% in 2022, then tumbled by 259 bps to 0.17% in 2023, then slumped by 277 bps to 0.65% in 2024, then jumped by 115 bps to 0.1% in 2025, then sank by 112 bps to 0.01% in 2026.
- According to Business Quant data, Tax Rate over the past three periods registered 0.01%, 0.1%, and 0.14% for Q2 2026, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 17.98% |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 15.47% |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | -95.75% |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | -23.71% |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 62.33% |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | -31.96% |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn | 24.15% |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 22.08% |
| 10 | X4 Pharmaceuticals | 510.43 Mn | 315.33 Mn | 7.19 Mn | -0.01% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.01% |
| Sep 30, 2025 | 0.10% |
| Jun 30, 2025 | -0.14% |
| Mar 31, 2025 | 10.76% |
| Dec 31, 2024 | -0.65% |
| Sep 30, 2024 | -0.04% |
| Jun 30, 2024 | 0.02% |
| Mar 31, 2024 | -0.04% |
| Dec 31, 2023 | -0.17% |
| Sep 30, 2023 | -1.14% |
| Jun 30, 2023 | -0.03% |
| Mar 31, 2023 | -0.02% |
| Dec 31, 2022 | -0.05% |
| Sep 30, 2022 | 0.06% |
| Jun 30, 2022 | -0.02% |
| Mar 31, 2022 | -0.10% |
| Dec 31, 2021 | -0.01% |
| Sep 30, 2021 | -0.01% |
| Jun 30, 2021 | -0.03% |
| Mar 31, 2021 | -0.03% |